Articles From: - Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Safe and Increases CD4 Counts in People Living With HIV to - Morningstar Reports U.S. Mutual Fund and ETF Asset Flows for October 2014


http://media.marketwire.com/attachments/201007/622573_BionorPharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159268&ProfileId=051205&sourceType=1 OSLO, NORWAY --
Sign-up for - Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Safe and Increases CD4 Counts in People Living With HIV investment picks
The U.S.-listed shares of Japanese companies are indicated lower in premarket trade Monday, after data showing that Japan's economy surprisingly .
Sign-up for - UPDATE: Japanese ADRs sell off ahead of Monday's open investment picks
Sonus Networks, Inc. (NASDAQ: SONS), a global leader in enabling and securing real-time communications and Westcon Group - the value-added distributor of security, Unified Communications, network infrastructure and data center solutions - today announced that Sonus’ complete line of Session Border Controllers (SBCs) is now available to U.S. government customers via the distributor’s General Services Administration (GSA) program.
Sign-up for - Sonus Networks and Westcon Group to Make Enablement and Security of Real-Time Communications Easily Accessible to U.S. Government investment picks
Shares of Apple Inc. (AAPL) traded above a pre-split value of $800 in intraday trade for the first time on Monday.
Sign-up for - Apple rises above $800 pre-split price investment picks
Results of industry benchmark study to be presented at IAOP 2015 Outsourcing World Summit STAMFORD, Conn.
Sign-up for - ISG and IAOP Announce Launch of 2015 State of the Industry Survey investment picks
Sevion Therapeutics, Inc. ("Sevion" or the "Company") (OTCQB:SVON), a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, today reported financial results for the fiscal quarter ended September 30, 2014 (“First Quarter 2015”). "During the first fiscal quarter of 2015, we made a strategic decision to focus our efforts and resources on our proprietary antibody discovery technology platforms, including two promising antibodies that are advancing toward IND status,” said Ronald Martell, Chief Executive Officer of Sevion.
Sign-up for - Sevion Therapeutics Reports First Quarter 2015 Financial Results investment picks
2014/11/17
By Carla Mozee, MarketWatch Halliburton buying Baker Hughes in $35 billion deal LONDON (MarketWatch) -- U.S. stock futures declined Monday, with Wall Street likely to start in the red after Japan -- the world's third-largest economy --
Sign-up for 2014/11/17 - UPDATE: U.S. stocks: Futures lower after Japan falls into recession investment picks
BURLINGTON, Mass., Nov.
Sign-up for - Flexion Therapeutics to Present at Stifel Healthcare Conference 2014 investment picks
By Jonathan D.
Sign-up for - Actavis to buy Allergan in $66 billion deal investment picks
2014/11/17
Testing digital technologies, remote sensors, icephobic wing coatings to reduce fuel use, emissions, noise SEATTLE , Nov.
Sign-up for 2014/11/17 - Boeing ecoDemonstrator 787 Tests Innovations for More Efficient Air Travel investment picks
http://media.marketwire.com/attachments/201106/76308_CalixlogoRGBon-screen.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159133&ProfileId=051205&sourceType=1 JACKSON, WY --
Sign-up for - Calix Enables 50th Gigabit Network With Silver Star in Jackson, Wyoming investment picks
Pepco Holdings, Inc. (PHI) vice president of Corporate Communications Laura Monica is the 2014 Washington PR Woman of the Year.
Sign-up for - Pepco Holdings Executive Wins Woman of the Year Award investment picks
SALT LAKE CITY , Nov.
Sign-up for - Extra Space Storage Inc. Ranked Among Top Workplaces investment picks
2014/11/17
NEW YORK , Nov.
Sign-up for 2014/11/17 - Genco Shipping & Trading Clarifies Change In Ticker Symbols investment picks
Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced positive top-line data from its randomized, double-blind, placebo- and active-controlled Phase 2a/b trial of TRV130 in moderate-to-severe postoperative acute pain.
Sign-up for - Trevena Announces Positive Top-Line Results from Phase 2a/b Study of TRV130 in Acute Postoperative Pain investment picks
Limelight Networks, Inc. (“Limelight”) (Nasdaq:LLNW), a global leader in digital content delivery, today announced its participation at Streaming Media West .
Sign-up for - Limelight Networks to Present at Streaming Media West investment picks
Cornerstone OnDemand (NASDAQ:CSOD), a global leader in cloud-based talent management software solutions, today announced that the company’s founder and CEO, Adam Miller, will present at the following investor conference: An audio webcast of the presentation will be available on Cornerstone OnDemand’s investor relations website at http://investors.cornerstoneondemand.com/events.cfm .
Sign-up for - Cornerstone OnDemand Management to Present at UBS Global Technology Conference investment picks
2014/11/17
DUBLIN, Ohio , Nov.
Sign-up for 2014/11/17 - You've Earned It: Reward Yourself with Wendy's Bacon Portabella Melt on Brioche investment picks
2014/11/17
The top 20 TV series on Xfinity On Demand for the week of November 2 – November 8 were: 1.
Sign-up for 2014/11/17 - Xfinity On Demand Top 20 TV Shows for the Week of November 2 – November 8 investment picks
Levi & Korsinsky is investigating the Board of Directors of Susquehanna Bancshares, Inc. (“Susquehanna” or “the Company”) (Nasdaq:SUSQ) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to BB&T Corporation (NYSE: BBT). Click here to learn more about the investigation: http://zlk.9nl.com/susquehannabancshares-susq .
Sign-up for - SUSQ INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation into the Board of Directors of Susquehanna Bancshares, Inc. in Connection With the Fairness of the Sale of the Company to BB&T Corporation investment picks
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of AmREIT Inc. (“AmREIT” or the “Company”) (NYSE: AMRE) by Edens Investment Trust (“Edens”), a private company.
Sign-up for - SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of AmREIT Inc. And Encourages Investors To Contact The Firm For Additional Information investment picks
GNCC Capital, Inc. (OTC: GNCP) (“The Company”) clarifies its position on its Stock Repurchase Program following this morning’s Press Release.
Sign-up for - GNCC Capital, Inc. Issues a Clarification investment picks
Cincinnati Bell Inc. (NYSE: CBB) today announced that Leigh Fox, chief financial officer of Cincinnati Bell Inc., will be presenting at the UBS 42 nd Annual Global Media and Communications Conference on Monday, December 8, 2014 at 9:30 a.m. EST.
Sign-up for - Cincinnati Bell to Present at UBS 42nd Annual Global Media and Communications Conference investment picks
2014/11/17
COLUMBIA, S.C., Nov.
Sign-up for 2014/11/17 - Photo Release -- First Citizens Announces New South Carolina Leadership Team for Combined Company investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: - Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Safe and Increases CD4 Counts in People Living With HIV to - Morningstar Reports U.S. Mutual Fund and ETF Asset Flows for October 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent